XML 120 R106.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule of Sales and Operating Income from Continuing Operations by Operating Segment (Details)
$ in Thousands
12 Months Ended
Jan. 02, 2022
USD ($)
segments
Jan. 03, 2021
USD ($)
Dec. 29, 2019
USD ($)
Schedule of Segment Reporting Information, by Segment [Line Items]      
Operating income from continuing operations $ 1,332,378 $ 978,581 $ 361,973
Number of Operating Segments | segments 2    
Revenue from Contract with Customer, Excluding Assessed Tax $ 5,067,169 3,782,745 2,883,673
Interest and other expense (income), net 52,492 72,217 124,831
Income from continuing operations before income taxes 1,279,886 906,364 237,142
Acceleration of executive compensation     7,700
Asset Impairment Charges 3,868 7,937 0
Significant environmental matters   5,200  
Diagnostics [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Operating income from continuing operations 1,219,944 874,206 189,330
Revenue from Contract with Customer, Excluding Assessed Tax 2,931,939 2,066,942 1,137,512
Asset Impairment Charges 3,900 7,900  
Discovery & Analytical Solutions [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Operating income from continuing operations [1] 189,798 183,471 238,331
Revenue from Contract with Customer, Excluding Assessed Tax 2,135,230 1,715,803 1,746,161
Corporate [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Operating income from continuing operations [2] (77,364) (79,096) (65,688)
Particular Diagnostics Case [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Legal Fees 100 1,200 100
Particular Discovery & Analytical Solutions Case [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Legal Fees   5,900 2,200
Product [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 3,329,102 2,778,725 2,017,042
Product [Member] | Diagnostics [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,970,618 1,783,509 962,180
Product [Member] | Discovery & Analytical Solutions [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,358,484 995,216 1,054,862
Service [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,738,067 1,004,020 866,631
Service [Member] | Diagnostics [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 961,321 283,433 175,332
Service [Member] | Discovery & Analytical Solutions [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 776,746 $ 720,587 $ 691,299
[1] Legal costs for significant litigation matters and settlements in the Company's Discovery & Analytical Solutions segment were $5.9 million and $2.2 million for fiscal years 2020 and 2019, respectively. Legal costs for significant litigation matters and settlements in the Company's Diagnostics segment were $0.1 million, $1.2 million and $0.1 million for fiscal years 2021, 2020 and 2019, respectively.(2)Asset impairment in the Company's Diagnostics segment was $3.9 million and $7.9 million for fiscal years 2021 and 2020.
[2] Costs for significant environmental matters were $5.2 million for fiscal year 2020. Stock compensation expense from acceleration of executive compensation was $7.7 million for fiscal year 2019.